The Bioscreen™ instrument was originally developed by the Finnish biotechnology company Labsystems Oy Ltd. back in the 1980’s. It was the successor to Labsystems Mutascreen™ analyzing system, which was developed to measure mutagenicity of chemicals, such as medications, pesticides, additives in nutrition, cosmetics etc. The Mutascreen-project was suspended in 1985 and the Bioscreen era begun.

The Bioscreen instruments are built to last and in continious daily use all over the world. This is perhaps best described by the fact that we're still servicing the second Bioscreen C, ever made, today - over 40 years later, which tells you everything about the remarkable Bioscreen quality, and robustness, that it is well known for today.

The Bioscreen C MBR was replaced by the new, silent and further improved Bioscreen G Pro™ model in 2019. In 2025, the latest version — the Bioscreen G Pro Gas™ instrument — was introduced to the market. It has become a sought-after alternative, as customers at top universities, government institutions and privately held corporate laboratories around the world have demonstrated that an anaerobic model of the Bioscreen has long been awaited by its users. This is best proven by the thousands of publications using Bioscreen instruments, that today can be found on Google Scholar.